Saesco Medical

Who owns Saesco Medical?

Saesco Medical is currently owned by Miura Partners through Miura Fund IV (2023 vintage), since 2025.

Hand-verified · updated 2026-08-02

About Saesco Medical

Saesco Medical is a Barcelona-based distributor of medical devices and single-use consumables for minimally invasive surgery, supplying hospitals across specialties that include obesity, gynaecology, urology, general surgery and interventional cardiology. The group operates through a portfolio of specialist brands, among them Medispar, Medical Dynamics, Pelvitec, HMS Endo, Fixaplus, Cardiolink, Rivolution and Dimed, and distributes more than 600 products on an exclusive basis. It sells to over 2,000 public and private healthcare providers and maintains direct commercial operations across several European countries, including Spain, Belgium, the Netherlands, Italy, Germany and Poland. On a combined basis the group generates over EUR 50 million in revenue, positioning it as a mid-sized European consolidator in the fragmented surgical-devices distribution market.

Ownership journey

Saesco was founded in Barcelona in 2009 by the Saenger Escola family and Jordi Fluvia, who continues to lead the group as chief executive. Having pursued a buy-and-build strategy with a series of integrations from 2019 onward, the company brought in Miura Partners as its equity backer in May 2025, when the Spanish mid-market firm invested through Miura Fund IV via a capital increase to fund international consolidation. Miura took a shareholding of close to half the company's capital and remains the current equity owner alongside the founding management, with the group still listed among its portfolio companies. No exit or secondary transaction has been recorded.

Under PE ownership

The Miura investment was structured as growth capital to accelerate cross-border acquisitions and broaden the product range. Concurrent with the backing, Saesco acquired Cardiolink, a Spanish distributor specializing in cardiac and interventional cardiology, strengthening its position in the Iberian public-hospital network. It subsequently entered the German market through the purchase of Rivolution GmbH, added the Italian distributor Medcomp, and acquired the production unit of Catalan supplier Sanguesa, extending its footprint from pure distribution into manufacturing. These moves brought the group's total acquisitions since 2019 to around ten and expanded its direct presence to seven European countries, consolidating a platform that combines multiple specialist brands under a single operating structure.